diabetes. 3 Structured diabetes education delivered in routine practice for persons with type 1 diabetes have been found to at least halving rates of severe hypoglycaemia (SH) 4 and lead to reduced emergency treatment costs. 5 Past experience of SH is associated with greater fear of hypoglycaemia (FoH) in individuals with type 1 diabetes, suggesting that the experience of hypoglycaemia plays an important role in triggering FoH. 2, [6] [7] [8] [9] FoH is recognized as a complex and common phenomenon affecting quality of life and diabetes management for individuals with type 1 diabetes. 9 Furthermore, worries about hypoglycaemia are also common in family members. 10 In a large cohort study, we found gender differences in FoH, suggesting that females are more affected by FoH than men. In addition, impaired awareness of hypoglycaemia (IAH), frequency of mild hypoglycaemia, number of symptoms during mild hypoglycaemia, number of hypoglycaemic symptoms during hyperglycaemia, HbA 1c, and visits to the emergency department because of hyperglycaemia were identified as significant factors associated with FoH. 6 A recent study in young adults (aged 18-35 years)
with type 1 diabetes showed that FoH was associated with greater glycaemic variability and with higher calorie intake and less physical activity. 11 Furthermore, other associations have been shown between FoH diabetes-related quality of life and psychological well-being 12 and personality traits such as anxiety. 7, 13 FoH is greater at night and may contribute to poor sleep quality. 
| PATIENTS AND METHODS

| Participants and procedure
In 2010, 764 patients who participated in a previous FOH study 6 received a consent form and a set of questionnaires by mail. In the original study, the inclusion criteria were type 1 diabetes, age 
| Questionnaires
Cox et al. 15 
| Statistical analysis
Statistical analysis was performed using spss 22 for Windows (spss Inc.;
Chicago, IL, USA).
Responders with an absolute difference in HFS scores ≥75th percentile were included in the subgroup analyses. Statistical analyses included one-sample t tests, independent samples t tests, chi-square and McNemar's test, as appropriate.
| Ethical consideration
The study was approved by the regional ethical review board, Dnr-2006/1069-31/2.
| RESULTS
Of the 469 subjects who received the questionnaire in 2014, 74%
(n = 347) responded, 179 women and 168 men. There was one significant difference between responders and nonresponders with the latter having shorter diabetes duration (32.8 years vs 36.1 years, P .036). Descriptive data on all subjects can be found in Table 1 Between-groups analyses showed that there was a significant difference in long-acting insulin regimen between the decreased FoH group and the increased FoH group both in 2010 and in 2014. Table 2 .
| DISCUSSION
To our knowledge, this is the first longitudinal study of FoH in individuals with type 1 diabetes. Our study shows that FoH is stable across time for most people ( Figure 1 ). The absolute mean difference on the HFS over 4 years was ± 7.6 points (median ± 6.0). This study also found additional support for the gender difference found in 2010 that shows FoH to be more frequent among women.
However, the large range in absolute difference scores (−35 -+ 22) indicates that there are a number of individuals whose fear levels have changed dramatically, either up or down. Our subgroup data of these results confirm prior research that has shown the experience of hypoglycaemic episodes to be the factor with the strongest influence on the fear level. 9 In the group with increased FoH 2014, more participants have a high degree of moderate hypos compared to the de- 
T A B L E 1 Demographic and clinical characteristics of responders and nonresponders
F I G U R E 1 Each participant's individual scores on Hypoglycaemia Fear Survey (HFS) in 2010 (in blue) and in 2014 (in red)
A somewhat puzzling find is that there was a difference in insulin regimen between the increased FoH group and the decreased FoH group. More participants in the increased FoH group were on CSII compared to the decreased FoH group. However, there had not been a change in regimen between 2010 and 2014, subjects using a pump in 2014 were also using a pump in 2010. It could be speculated that this group consisted of people with more labile glucose control which is regarded as an indication for pump treatment in Sweden. A systematic review of the clinical effectiveness of CSII 18 found that compared to MDI, treatment with CSII shows reduction T A B L E 2 Between-group differences in self-monitoring of blood glucose (SMBG), hypoglycaemia history, demographic and medical variables 2010 and 2014 in swings in BG levels, fewer problems with hypoglycaemic episodes and a reduction in the chronic fear of SH. However, a study on FoH and CSII by 19 found that FoH is present in many people with CSII.
The study also found that the only significant associations to FoH were accumulated episodes of SH and rate of hypoglycaemia.
A limitation of this study is that hypoglycaemia history and SMBG are self-reported and may therefore be over-or underestimated.
This has been found in for instance the study by Cariou et al 2015. 20 Furthermore, the slight difference in diabetes duration between responders and nonresponders may indicate that subjects with a higher hypoglycaemia risk may have been more inclined to respond since a longer duration has been shown to be associated with risk of hypoglycaemia in previous studies. 2 To conclude, this study shows that FoH is persistent over time if not treated and that hypoglycaemia frequency is the strongest predictor of FoH. Thus, asking patients about the occurrence of hypoglycaemia is of the utmost importance as is helping them adequately detect, prevent and treat hypoglycaemia. In order to do so, psychological and behavioural difficulties must be assessed and addressed using psychological methods and therapeutic education. 
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